Correlation Between Roivant Sciences and Genscript Biotech

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Roivant Sciences and Genscript Biotech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Roivant Sciences and Genscript Biotech into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Roivant Sciences and Genscript Biotech, you can compare the effects of market volatilities on Roivant Sciences and Genscript Biotech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Roivant Sciences with a short position of Genscript Biotech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Roivant Sciences and Genscript Biotech.

Diversification Opportunities for Roivant Sciences and Genscript Biotech

-0.25
  Correlation Coefficient

Very good diversification

The 3 months correlation between Roivant and Genscript is -0.25. Overlapping area represents the amount of risk that can be diversified away by holding Roivant Sciences and Genscript Biotech in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genscript Biotech and Roivant Sciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Roivant Sciences are associated (or correlated) with Genscript Biotech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genscript Biotech has no effect on the direction of Roivant Sciences i.e., Roivant Sciences and Genscript Biotech go up and down completely randomly.

Pair Corralation between Roivant Sciences and Genscript Biotech

Assuming the 90 days horizon Roivant Sciences is expected to generate 1.74 times more return on investment than Genscript Biotech. However, Roivant Sciences is 1.74 times more volatile than Genscript Biotech. It trades about 0.1 of its potential returns per unit of risk. Genscript Biotech is currently generating about -0.01 per unit of risk. If you would invest  128.00  in Roivant Sciences on August 25, 2024 and sell it today you would earn a total of  140.00  from holding Roivant Sciences or generate 109.38% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy31.99%
ValuesDaily Returns

Roivant Sciences  vs.  Genscript Biotech

 Performance 
       Timeline  
Roivant Sciences 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Roivant Sciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly stable basic indicators, Roivant Sciences is not utilizing all of its potentials. The latest stock price fuss, may contribute to near-short-term losses for the sophisticated investors.
Genscript Biotech 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Genscript Biotech has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest fragile performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders.

Roivant Sciences and Genscript Biotech Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Roivant Sciences and Genscript Biotech

The main advantage of trading using opposite Roivant Sciences and Genscript Biotech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Roivant Sciences position performs unexpectedly, Genscript Biotech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genscript Biotech will offset losses from the drop in Genscript Biotech's long position.
The idea behind Roivant Sciences and Genscript Biotech pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.

Other Complementary Tools

Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm